Screening for Atherotic Plaques by Ultrasound for Assessing Cardiovascular Risk

NCT ID: NCT03499496

Last Updated: 2018-04-17

Basic Information

• Recruitment Status: COMPLETED
• Total Enrollment: 22 participants
• Study Classification: OBSERVATIONAL
• Study Start Date: 2016-01-15
• Study Completion Date: 2016-09-04

Brief Summary

Cardiovascular disease is a common diagnosed and treated condition in private practices of primary health care. There is growing evidence that atherosclerotic plaques as predictors for stroke and heart attack are more prevalent than expected based on the clinical score in people with low risk for stroke and heart attack .

Diagnosing atherosclerotic plaques can help to decide if a lipid lowering therapy should be prescribed even if the clinical risk score is low or on the other hand if they can be observed even in high lipid levels.

Detailed Description

Both common and proximal internal carotid arteries and both common femoral arteries (including bifurcations) were screened by ultrasound in patients who came for a check-up to a primary care practice with no known cardiovascular disease and low risk for stroke and heart attack according to the AGLA/GSLA risk score which is mostly used in Switzerland.

All patients agreed and gave written informed consent to be included in this study. Presence of plaques was defined as a focal carotid intima-media thickness >0.5 cm on ultrasound. Screening was performed by a medical doctor (DP) certified for the procedure using the following ultrasound system: Toshiba Nemio XG, probe 7.5 MhZ.

Conditions

Atherosclerosis of Artery

Study Design

• Observational Model Type: CASE_ONLY
• Study Time Perspective: RETROSPECTIVE

Interventions

ultrasound guided detection of atherosclerotic plaques

screening by ultrasound of atherosclerotic plaques

Intervention Type: DIAGNOSTIC_TEST

Eligibility Criteria

Inclusion Criteria

• low cardiovascular risk assessed by the AGLA/GSLA-score

Exclusion Criteria

• cardiovascular disease

• Minimum Eligible Age: 41 Years
• Maximum Eligible Age: 72 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: Yes

Sponsors

Cabinet de Medecine Interne Générale Demetrio Pitarch

OTHER

Sponsor Role: lead

Responsible Party

Responsibility Role: SPONSOR

Principal Investigators

Demetrio A Pitarch, MD

Role: PRINCIPAL_INVESTIGATOR

Cabinet de medecine generale

Other Identifiers

DPitarch

Identifier Type: -

Identifier Source: org_study_id